Waveflu 75 Capsule contains Oseltamivir Phosphate 30 mg, a neuraminidase inhibitor antiviral used for the treatment and prophylaxis of influenza A and B.
It works by inhibiting viral neuraminidase, preventing the release of new viral particles, which reduces viral replication and shortens the course of illness. Waveflu 75 helps in alleviating fever, cough, sore throat, and body aches, supporting faster recovery and symptom relief.
Clinically, Waveflu 75 Capsule is indicated for patients diagnosed with influenza, those at high risk of flu complications, or as a preventive measure during outbreaks. The oral capsule formulation ensures accurate dosing, ease of administration, and high patient compliance.
From a business perspective, Waveflu 75 Capsule strengthens the antiviral therapy segment, widely prescribed in hospitals, clinics, and primary care setups, offering consistent demand, repeat prescriptions, and reliable clinical performance, making it a valuable addition for pharma partners.